Dag Hofsø

Dag Hofsø

Auto-generated profile, based on publicly available information

Dag Hofsø

Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
EAErlend T Aasheim
Erlend T Aasheim
DHDag Hofsø
Dag Hofsø
JHJøran Hjelmesæth
Jøran Hjelmesæth
KBKåre I Birkeland
Kåre I Birkeland
TBThomas Bøhmer
Thomas Bøhmer
Background: Morbid obesity is associated with low circulating concentrations of 25-hydroxyvitamin D. Few data on the concentrations of other vitamins in morbidly obese patients are available. Objective: The objective was to compare serum and blood vitamin concentrations in morbidly obese patients with those in healthy subjects. Design: In 2 public hospital departments (southeast Norway), we prospectively examined 110 consecutive patients (76 women) and 58 healthy controls (30 women) not taking multivitamin supplements. Patients and controls did not differ significantly in age or ethnicity. The mean (±SD) body mass index (in kg/m2) was 45 ± 7 in the patients and was 24 ± 3 in the controls. Patients with vitamin concentrations lower than 2 SD below the sex-specific mean in controls were considered to have inadequate vitamin status. Results: The morbidly obese women and men had significantly lower concentrations of vitamin B-6, vitamin C, 25-hydroxyvitamin D, and lipid-standardized vitamin E than did the healthy controls (P < 0.01 for each). The status of these vitamins was inadequate in a substantial proportion of the patients (11–38%). The status of vitamins A, B-1, B-2, and B-12 and of folic acid was adequate in most of the patients (95–100%). A moderately elevated C-reactive protein concentration was associated with lower vitamin A, B-6, and C concentrations. In a multiple regression analysis, concentrations of alkaline phosphatase (inverse relation) and vitamin C were the strongest determinants of serum vitamin B-6 concentrations. Conclusions: Low concentrations of vitamin B-6, vitamin C, 25-hydroxyvitamin D, and vitamin E adjusted for lipids are prevalent in morbidly obese Norwegian patients seeking weight-loss treatment.

1 November 2010 in European Journal of Endocrinology
Verified
Journal Article
Open access
DHD Hofsø
D Hofsø
NNN Nordstrand
N Nordstrand
LJL K Johnson
L K Johnson
TKT I Karlsen
T I Karlsen
HHH Hager
H Hager
JHJ Hjelmesæth
J Hjelmesæth
Objective: Weight reduction improves several obesity-related health conditions. We aimed to compare the effect of bariatric surgery and comprehensive lifestyle intervention on type 2 diabetes and obesity-related cardiovascular risk factors.Design: One-year controlled clinical trial (ClinicalTrials.gov identifier NCT00273104).Methods: Morbidly obese subjects (19–66 years, mean (s.d.) body mass index 45.1 kg/m2(5.6), 103 women) were treated with either Roux-en-Y gastric bypass surgery (n=80) or intensive lifestyle intervention at a rehabilitation centre (n=66). The dropout rate within both groups was 5%.Results: Among the 76 completers in the surgery group and the 63 completers in the lifestyle group, mean (s.d.) 1-year weight loss was 30% (8) and 8% (9) respectively. Beneficial effects on glucose metabolism, blood pressure, lipids and low-grade inflammation were observed in both groups. Remission rates of type 2 diabetes and hypertension were significantly higher in the surgery group than the lifestyle intervention group; 70 vs 33%,P=0.027, and 49 vs 23%,P=0.016. The improvements in glycaemic control and blood pressure were mediated by weight reduction. The surgery group experienced a significantly greater reduction in the prevalence of metabolic syndrome, albuminuria and electrocardiographic left ventricular hypertrophy than the lifestyle group. Gastrointestinal symptoms and symptomatic postprandial hypoglycaemia developed more frequently after gastric bypass surgery than after lifestyle intervention. There were no deaths.Conclusions: Type 2 diabetes and obesity-related cardiovascular risk factors were improved after both treatment strategies. However, the improvements were greatest in those patients treated with gastric bypass surgery.

1 January 2009 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
JHJøran Hjelmesæth
Jøran Hjelmesæth
DHDag Hofsø
Dag Hofsø
EAErlend T Aasheim
Erlend T Aasheim
TJTrond Jenssen
Trond Jenssen
JMJohan Moan
Johan Moan
JBJens Bollerslev
Jens Bollerslev
The prevalence of vitamin D insufficiency and secondary hyperparathyroidism is high among morbidly obese subjects. Further, low serum levels of 25-hydroxyvitamin D (25 [OH]D) and magnesium have been associated with increased risk of the metabolic syndrome (MS), and recently, a possible link between PTH and MS has been reported. Although it is well known that the synthesis and secretion of PTH is regulated by serum levels of calcium, phosphate, magnesium and 25(OH)D, less is known about the possible clustered affiliation of these parameters with MS. We aimed to explore whether MS is associated with abnormal serum levels of PTH, 25(OH)D and magnesium in a population of morbidly obese patients.

1 February 2011 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
NNN Nordstrand
N Nordstrand
EGE Gjevestad
E Gjevestad
KDKn Dinh
Kn Dinh
DHD Hofsø
D Hofsø
JRJ Røislien
J Røislien
JHJøran Hjelmesæth
Jøran Hjelmesæth
Obesity is associated with increased risk of cardiovascular disease. Arterial stiffness assessed by carotid femoral pulse wave velocity (PWV) is an independent predictor of cardiovascular morbidity and mortality. We aimed to investigate how various measures of body composition affect arterial stiffness.

5 November 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
DHDag Hofsø
Dag Hofsø
THThor Olav Widerøe Hillestad
Thor Olav Widerøe Hillestad
EHErling Halvorsen
Erling Halvorsen
FFFarhat Fatima
Farhat Fatima
LJLine Kristin Johnson
Line Kristin Johnson
JHJøran Hjelmesæth
Jøran Hjelmesæth
Context Bariatric surgery, particularly Roux-en-Y gastric bypass (RYGB), is associated with an increased risk of osteoporotic fractures. It is unknown whether RYGB or sleeve gastrectomy (SG) have different effects on bone health. Objective To compare changes in bone mineral density and markers of bone turnover 1 year after SG and RYGB. Design, Setting, Patients, and Interventions Randomized, triple-blind, single-center trial at a tertiary care center in Norway. The primary outcome was diabetes remission. Patients with severe obesity and type 2 diabetes were randomized and allocated (1:1) to SG or RYGB. Main Outcome Measures Changes in areal bone mineral density (aBMD) and bone turnover markers. Results Femoral neck, total hip, and lumbar spine aBMD, but not total body aBMD, decreased significantly more after RYGB (n = 44) than after SG (n = 48) (mean [95% confidence interval] between group differences -2.8% [-4.7 to -0.8], -3.0% [-5.0 to -0.9], -4.2% [-6.4 to -2.1], and -0.5% [-1.6 to 0.6], respectively). The increase in procollagen type 1 N-terminal propeptide (P1NP) and C-telopeptide of type I collagen (CTX-1) were approximately 100% higher after RYGB than after SG (between group difference at 1 year, both P < 0.001). The changes in femoral neck, total hip, and lumbar spine aBMDs and the changes in P1NP and CTX-1 were independently associated with the surgical procedure (all P < 0.05) and not weight change. Conclusions Roux-en-Y gastric bypass was associated with a greater reduction in aBMD and a greater increase in bone turnover markers compared with SG. This finding could suggest greater skeletal fragility after RYGB.

1 December 2016 in JAMA Surgery
Verified
Journal Article
Closed access
PDF file
HRHilde Risstad
Hilde Risstad
MSMarius Svanevik
Marius Svanevik
JKJon A. Kristinsson
Jon A. Kristinsson
JHJøran Hjelmesæth
Jøran Hjelmesæth
EAErlend T. Aasheim
Erlend T. Aasheim
TMTom Mala
Tom Mala
This randomized clinical trial assesses the efficacy and safety of standard gastric bypass vs distal gastric bypass in patients with a BMI of 50 to 60.